Skip to main content
Top
Published in: Clinical Research in Cardiology 5/2012

Open Access 01-05-2012 | Original Paper

Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation

Authors: I. Akin, S. Kische, H. Schneider, A. Liebold, J. Ortak, D. Bänsch, T. C. Rehders, O. Thiele, R. Schneider, G. Kundt, H. Krenz, T. Chatterjee, C. A. Nienaber, H. Ince

Published in: Clinical Research in Cardiology | Issue 5/2012

Login to get access

Abstract

Background

Transcatheter aortic valve implantation (TAVI) has been developed to minimize operative morbidity and mortality in high-risk symptomatic patients unfit for open surgery. With the proximity of the aortic valve annulus to the conduction system there is, however, an unknown risk of conduction disturbances necessitating monitoring and often cardiac pacing.

Materials and methods

We enrolled 50 consecutive patients from January 2007 to 2008 in our prospective evaluation of conduction disturbances measured by surface and intracardiac ECG recordings. Baseline parameters, procedural characteristics as well as twelve-lead surface ECG and intracardiac conduction times were revealed pre-interventionally, after TAVI and at 7-day follow-up.

Results

TAVI was performed successfully in all patients. During 7 days of follow-up the rate for first-degree AV block raised from 14% at baseline to 44% at day 7 (p < 0.001), while rates for type II second- and third-degree were 0 versus 8% (p < 0.001) and 0 versus 12% (p < 0.001), respectively. Similarly, the prevalence of new left bundle branch block (LBBB) rose from 2 to 54% (p < 0.001). Intracardiac measurements revealed a prolongation of both AH and HV interval from 123.7 ± 41.6 to 136.6 ± 40.5 ms (p < 0.001) and from 54.8 ± 11.7 to 71.4 ± 20.0 ms (p < 0.001), respectively. Pacemaker implantation at a mean follow-up of 4.8 ± 1.2 days was subsequently performed in 23 patients (46%) due to complete AV block (12%) and type II second-degree AV block (8%) while another 13 patients (26%) received a pacemaker for the combination of new LBBB with marked HV prolongation. The high rate of first-degree AV block was primarily driven by an increase in HV interval.

Conclusion

Cardiac conduction disturbances were common in the early experience with CoreValve implantation necessitating close surveillance for at least 1 week.
Literature
1.
go back to reference Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011PubMedCrossRef Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011PubMedCrossRef
2.
go back to reference Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A (2007) Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines Guidelines on the management on valvular heart disease of the European Society of Cardiology. Eur Heart J 28:230–268PubMed Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A (2007) Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines Guidelines on the management on valvular heart disease of the European Society of Cardiology. Eur Heart J 28:230–268PubMed
3.
go back to reference Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society of Cardiovascular Anaesthesiologists: endorsed by the Society for Cardiovascular Angiography and interventions and society of thoracic surgeons. Circulation 52:e1–e142 Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society of Cardiovascular Anaesthesiologists: endorsed by the Society for Cardiovascular Angiography and interventions and society of thoracic surgeons. Circulation 52:e1–e142
4.
go back to reference Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231–1243PubMedCrossRef Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231–1243PubMedCrossRef
5.
go back to reference Varadarajan P, Kapoor N, Bansal RC, Pai RG (2006) Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 82:2111–2115PubMedCrossRef Varadarajan P, Kapoor N, Bansal RC, Pai RG (2006) Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 82:2111–2115PubMedCrossRef
6.
go back to reference Shareghi S, Rasouli L, Shavelle DM, Burstein S, Matthews RV (2007) Current results of balloon aortic valvuloplasty in high-risk patients. J Invasive Cardiol 19:1–5PubMed Shareghi S, Rasouli L, Shavelle DM, Burstein S, Matthews RV (2007) Current results of balloon aortic valvuloplasty in high-risk patients. J Invasive Cardiol 19:1–5PubMed
7.
go back to reference Sack S, Kahlert P, Khandanpour S, Naber C, Philip S, Möhlenkamp S, Sievers B, Kälsch H, Erbel R (2008) Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol 97:288–297PubMedCrossRef Sack S, Kahlert P, Khandanpour S, Naber C, Philip S, Möhlenkamp S, Sievers B, Kälsch H, Erbel R (2008) Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol 97:288–297PubMedCrossRef
8.
go back to reference El-Khally Z, Thibault B, Stainloae C, Theroux P, Dubuc M, Roy D, Guerra P, Macle L, Talajic M (2004) Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am J Cardiol 94:1008–1011PubMedCrossRef El-Khally Z, Thibault B, Stainloae C, Theroux P, Dubuc M, Roy D, Guerra P, Macle L, Talajic M (2004) Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am J Cardiol 94:1008–1011PubMedCrossRef
9.
go back to reference Marchenese K, Schenk EA (1972) Atrioventricular conduction system lesion following cardiac valve replacement. Circulation 45–46(Suppl. II):II-188 Marchenese K, Schenk EA (1972) Atrioventricular conduction system lesion following cardiac valve replacement. Circulation 45–46(Suppl. II):II-188
10.
go back to reference Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T (2008) Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Intervention (EAPCI). Eur Heart J 29:1463–1470PubMedCrossRef Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T (2008) Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Intervention (EAPCI). Eur Heart J 29:1463–1470PubMedCrossRef
11.
go back to reference Figulla HR, Cremer J, Walther T, Gerckens U, Erbel R, Osterspey A, Zahn R (2009) Positionspapier zur kathetergeführten Aortenklappenintervention. Kardiologe 3:199–206CrossRef Figulla HR, Cremer J, Walther T, Gerckens U, Erbel R, Osterspey A, Zahn R (2009) Positionspapier zur kathetergeführten Aortenklappenintervention. Kardiologe 3:199–206CrossRef
12.
go back to reference Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richadt G, Figulla HR, Senges J, Investigators German Transcatheter Aortic Valve Intervention-Registry (2011) Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32:198–204PubMedCrossRef Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richadt G, Figulla HR, Senges J, Investigators German Transcatheter Aortic Valve Intervention-Registry (2011) Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32:198–204PubMedCrossRef
13.
go back to reference Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114:1616–1624PubMedCrossRef Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114:1616–1624PubMedCrossRef
14.
go back to reference Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76PubMedCrossRef Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76PubMedCrossRef
15.
go back to reference Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S (2006) Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113:842–850PubMedCrossRef Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S (2006) Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113:842–850PubMedCrossRef
16.
go back to reference Zahn R, Schiele R, Kilkowski C, Klein B, Zeymer U, Werling C, Lehmann A, Layer G, Saggau W (2010) There are two sides to everything: two case reports on sequelae of rescue interventions to treat complications of transcatheter aortic valve implantation of the Medtronic CoreValve prosthesis. Clin Res Cardiol 99:579–585PubMedCrossRef Zahn R, Schiele R, Kilkowski C, Klein B, Zeymer U, Werling C, Lehmann A, Layer G, Saggau W (2010) There are two sides to everything: two case reports on sequelae of rescue interventions to treat complications of transcatheter aortic valve implantation of the Medtronic CoreValve prosthesis. Clin Res Cardiol 99:579–585PubMedCrossRef
17.
go back to reference Zahn R, Schiele R, Kilkowski C, Zeymer U (2010) Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol 99:193–197PubMedCrossRef Zahn R, Schiele R, Kilkowski C, Zeymer U (2010) Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol 99:193–197PubMedCrossRef
18.
go back to reference Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–822PubMedCrossRef Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–822PubMedCrossRef
19.
go back to reference Yater WM, Cornell VH (1935) Heart block due to calcareous lesions of the bundle of His. Ann Int Med 8:777 Yater WM, Cornell VH (1935) Heart block due to calcareous lesions of the bundle of His. Ann Int Med 8:777
20.
go back to reference Ablaza SG, Blanco G, Maranhao V, Morse DP, Nichols HT (1968) Calcific aortic valvular disease associated with complete heart block. Case reports of successful correction. Dis Chest 54:457–460PubMedCrossRef Ablaza SG, Blanco G, Maranhao V, Morse DP, Nichols HT (1968) Calcific aortic valvular disease associated with complete heart block. Case reports of successful correction. Dis Chest 54:457–460PubMedCrossRef
21.
go back to reference Schwartz LS, Goldfischer J, Sprague GJ, Schwartz SP (1969) Syncope and sudden death in aortic stenosis. Am J Cardiol 23:647–658PubMedCrossRef Schwartz LS, Goldfischer J, Sprague GJ, Schwartz SP (1969) Syncope and sudden death in aortic stenosis. Am J Cardiol 23:647–658PubMedCrossRef
22.
go back to reference Copeland JG, Griepp RB, Stinson EB, Shumway NE (1977) Long-term follow-up after isolated aortic valve replacement. J Thorac Cardiovasc Surg 74:875–889PubMed Copeland JG, Griepp RB, Stinson EB, Shumway NE (1977) Long-term follow-up after isolated aortic valve replacement. J Thorac Cardiovasc Surg 74:875–889PubMed
23.
go back to reference Marcheix B, Lamarche Y, Berry C, Asgar A, Laborde JC, Basmadjian A, Ducharme A, Denault A, Bonan R, Cartier R (2007) Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg 134:1150–1156PubMedCrossRef Marcheix B, Lamarche Y, Berry C, Asgar A, Laborde JC, Basmadjian A, Ducharme A, Denault A, Bonan R, Cartier R (2007) Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg 134:1150–1156PubMedCrossRef
24.
go back to reference Scheinman MM, Peters RW, Modin G, Brennan M, Mies C, O’Young J (1977) Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation 56:240–244PubMed Scheinman MM, Peters RW, Modin G, Brennan M, Mies C, O’Young J (1977) Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation 56:240–244PubMed
25.
go back to reference Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW (2008) American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE Guideline. Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons (2008) ACC/AHA/HRS 2008 Guidelines dor Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51:e1–e62PubMedCrossRef Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW (2008) American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE Guideline. Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons (2008) ACC/AHA/HRS 2008 Guidelines dor Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51:e1–e62PubMedCrossRef
26.
go back to reference Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW (2008) Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 1:310–316PubMedCrossRef Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW (2008) Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 1:310–316PubMedCrossRef
27.
go back to reference Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, García-García H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P, Serruys PW (2010) Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 6:475–484PubMedCrossRef Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, García-García H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P, Serruys PW (2010) Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 6:475–484PubMedCrossRef
28.
go back to reference Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P, Cheung A, Ye J, Kerr C, Lichtenstein SV, Webb JG (2008) Atrioventricular block after transcatheter balloon expandable aortic valve implantation. J Am Coll Cardiol Intv 1:305–309 Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P, Cheung A, Ye J, Kerr C, Lichtenstein SV, Webb JG (2008) Atrioventricular block after transcatheter balloon expandable aortic valve implantation. J Am Coll Cardiol Intv 1:305–309
29.
go back to reference Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MW, Schuler G, Mohr FW (2008) Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 33:983–988PubMedCrossRef Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MW, Schuler G, Mohr FW (2008) Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 33:983–988PubMedCrossRef
Metadata
Title
Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation
Authors
I. Akin
S. Kische
H. Schneider
A. Liebold
J. Ortak
D. Bänsch
T. C. Rehders
O. Thiele
R. Schneider
G. Kundt
H. Krenz
T. Chatterjee
C. A. Nienaber
H. Ince
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Clinical Research in Cardiology / Issue 5/2012
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-011-0400-6

Other articles of this Issue 5/2012

Clinical Research in Cardiology 5/2012 Go to the issue